FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruce Werness

Research Profile

Disorders

Genes & Molecular Sequences

Procedures

Physiology

Phenomena

Polymorphism, Single-Stranded Conformational

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Brigitte M Ronnett; Andre A. Kajdacsy-Balla; C Blake Gilks; Maria J Merino; Elvio Silva; Bruce A Werness; Robert H Young
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Bruce A Werness; Susan J Ramus; Richard A DiCioccio; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Yoshiaki Tsukada; Patricia Harrington; Simon A Gayther; Bruce A J Ponder; M Steven Piver
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
Richard A DiCioccio; Bruce A Werness; M Steven Piver
BRCA1 mutations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruce Werness (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Brigitte M Ronnett; Andre A. Kajdacsy-Balla; C Blake Gilks; Maria J Merino; Elvio Silva; Bruce A Werness; Robert H Young
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Human pathology 2004;35(8):949-60.
2004: Bruce A Werness; Susan J Ramus; Richard A DiCioccio; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Yoshiaki Tsukada; Patricia Harrington; Simon A Gayther; Bruce A J Ponder; M Steven Piver
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(1):29-34.
2003: Richard A DiCioccio; Bruce A Werness; M Steven Piver
BRCA1 mutations.
Genes, chromosomes & cancer 2003;37(2):222.
2003: Susan J Ramus; Paul D P Pharoah; Patricia Harrington; Carole Pye; Bruce A Werness; Lynda Bobrow; Ayse Ayhan; Dagan Wells; Ami Fishman; Martin Gore; Richard A DiCioccio; M Steven Piver; Alice S Whittemore; Bruce A J Ponder; Simon A Gayther
BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Cancer research 2003;63(2):417-23.
2002: Manja Wobus; Robin Kuns; Irene Sheyn; Bruce A Werness; Nader Husseinzadeh; Bernard S Aron; Larry S Sherman
Endometrial carcinoma cells are nonpermissive for CD44-erbB2 interactions.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2002;10(3):242-6.
2002: Bruce A Werness; Richard A DiCioccio
Transitional cell ovarian carcinoma in a BRCA1 mutation carrier.
Obstetrics and gynecology 2002;100(2):385; author reply 385.
2001: Alaa M Afify; AW Ferguson; Rosa M Davila; Bruce A Werness
Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(4):309-14.
2001: Manja Wobus; Robin Kuns; C Wolf; Lars-Christian Horn; U Köhler; Irene Sheyn; Bruce A Werness; Larry S Sherman
CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
Gynecologic oncology 2001;83(2):227-34.
2001: Bruce A Werness; Gamal H Eltabbakh
Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2001;20(1):48-63.
2000: Bruce A Werness; Susan J Ramus; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Richard A DiCioccio; Yoshiaki Tsukada; Bruce A J Ponder; M Steven Piver
Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
Human pathology 2000;31(11):1420-4.
2000: Bruce A Werness; Susan J Ramus; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Richard A DiCioccio; Yoshiaki Tsukada; Bruce A J Ponder; M Steven Piver
Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(4):390-4.
2000: M Steven Piver; Y Tsukada; Bruce A Werness; Richard A DiCioccio; A S Whittemore; bruce ponder
Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry.
Gynecologic oncology 2000;78(2):166-70.
2000: Bruce A Werness; P Parvatiyar; Susan J Ramus; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Richard A DiCioccio; Jonathan S Wiest; Yoshiaki Tsukada; Bruce A J Ponder; M Steven Piver
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Journal of the National Cancer Institute 2000;92(13):1088-91.
2000: Bruce A Werness; Gamal H Eltabbakh
Ovarian dysplasia identified by cul-de-sac aspiration: a reexamination of previously reported cases.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(2):190-1.
1999: Bruce A Werness; A N Freedman; M Steven Piver; M Romero-Gutierrez; E Petrow
Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
Gynecologic oncology 1999;75(3):413-8.
1999: Bruce A Werness; Alaa M Afify; Gamal H Eltabbakh; K Huelsman; M Steven Piver; J M Paterson
p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1999;18(4):338-43.
1999: HA Tworek; R Peng; S Fetzer; Bruce A Werness; M Steven Piver; HJ Allen; Richard A DiCioccio
Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
Cancer genetics and cytogenetics 1999;112(2):105-18.
1999: Alaa M Afify; Bruce A Werness; Hon Fong L Mark
HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
Experimental and molecular pathology 1999;66(2):163-9.
1999: S Kayastha; A N Freedman; M Steven Piver; J Mukkamalla; M Romero-Guittierez; Bruce A Werness
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1073-6.
1999: Hon Fong L Mark; Alaa M Afify; Bruce A Werness; S Das; S Mark; M Samy
Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization.
Experimental and molecular pathology 1999;66(1):76-81.
1999: Bruce A Werness; Alaa M Afify; K L Bielat; Gamal H Eltabbakh; M Steven Piver; J M Paterson
Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer.
Human pathology 1999;30(2):151-7.
1998: John D Urschel; John S J Brooks; Bruce A Werness; JG Antkowiak; H Takita
Metachronous benign solitary fibrous tumours of the pleura (localized "mesotheliomas"): a case report.
Canadian journal of surgery. Journal canadien de chirurgie 1998;41(6):467-9.
1998: Gamal H Eltabbakh; Bruce A Werness; S Piver; LE Blumenson
Prognostic factors in extraovarian primary peritoneal carcinoma.
Gynecologic oncology 1998;71(2):230-9.
1998: C Wong; Richard A DiCioccio; HJ Allen; Bruce A Werness; M Steven Piver
Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation.
Cancer genetics and cytogenetics 1998;107(1):21-7.
1998: Richard A DiCioccio; Bruce A Werness; R Peng; HJ Allen; M Steven Piver
Correlation of TP53 mutations and p53 expression in ovarian tumors.
Cancer genetics and cytogenetics 1998;105(2):93-102.
1998: Gamal H Eltabbakh; M Steven Piver; RE Hempling; Bruce A Werness; LE Blumenson
Importance of lymph node metastases in primary peritoneal carcinoma.
Journal of surgical oncology 1998;68(3):144-8.
1998: I T Todorov; Bruce A Werness; H Q Wang; L N Buddharaju; P D Todorova; Harry K Slocum; John S J Brooks; Joel A Huberman
HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues.
Laboratory investigation; a journal of technical methods and pathology 1998;78(1):73-8.
1997: Gamal H Eltabbakh; M Steven Piver; Bruce A Werness
Primary peritoneal adenocarcinoma metastatic to the brain.
Gynecologic oncology 1997;66(1):160-3.
1997: Bruce A Werness; H Q Wang; J Chance; D J Goldstein
p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(6):578-84.
1997: Bruce A Werness; Richard A DiCioccio; M Steven Piver
Identical, unique p53 mutations in a primary ovarian mucinous adenocarcinoma and a synchronous contralateral ovarian mucinous tumor of low malignant potential suggest a common clonal origin.
Human pathology 1997;28(5):626-30.
1997: Bruce A Werness; J S Jobe; Richard A DiCioccio; M Steven Piver
Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(2):149-55.